Actionable insights straight to your inbox

Equities logo

What the Recent Run-Up in Ebola Stocks Taught Investors

A working knowledge of molecular biology is essential for a biotech investor, but it helps when someone with deep knowledge of science and medicine can bring understanding to the people who commit
When progress is made in drug development, value is created. Investors recognize that progress by purchasing shares in companies when milestones—which act as catalysts—are met. The